Aurobindo Pharma Gets FTC Approval for Lannett Acquisition

Transaction Background

Refers to previous disclosure dated July 30, 2025 regarding Aurobindo Pharma USA Inc. (wholly-owned subsidiary) entering into a definitive agreement with Lannett Seller Holdco, Inc. for acquisition of 100% membership interest in Lannett Company LLC.

Current Development

US Federal Trade Commission (FTC) has granted necessary approval for the acquisition of Lannett business. The approval was obtained on June 19, 2026.

Forward Outlook

Company anticipates the transaction will close before the end of June 2026. The exchanges will be informed of any future developments in this matter.